Skip to main content
. 2017 Sep 20;12(9):e0184766. doi: 10.1371/journal.pone.0184766

Table 2. Differences at last measurement between HIV patients who had never received TDF-containing ART(ARTTDF free), those who continuously took a TDF-containing ART (ARTTDF), and those who switched to TDF free (ARTswitched) at Chreso Ministries in Lusaka, Zambia 2011–2013.

ARTTDF free (N = 189) ARTTDF (N = 856) ARTswitched (N = 73)
variable N % mean sd N % mean sd N % mean sd p-value
Sex women 124 66 533 62 51 70 0.34a
duration of HIV infection [days] 189 100 2055 803 856 100 1511 789 73 100 1776 844 <0.001b
duration of ART intake [days] 189 100 1918 713 856 100 1357 791 73 100 1635 782 <0.001b
Age [years] 189 100 42.2 9.1 856 100 41.6 8.9 73 100 42.9 11.3 0.42b
BMI [kg/m2] men 48 74 23.3 4.2 271 84 23.1 4.2 18 82 24.4 4.3 0.45b
women 104 84 25.3 4.9 447 81 25.5 5.1 40 78 23.6 3.9 0.06b
mean arterial pressure [mmHg] 149 79 100.0 15.7 711 83 95.5 16.2 60 82 98.1 18.7 0.006b
systolic blood pressure [mmHg] 149 79 134.3 22.1 711 83 127.1 22.1 60 82 131.9 26.1 <0.001b
CD4 [ml-1] 147 78 455 251 689 80 407 203 41 56 404 247 0.05b
haemoglobin [g/dl] 137 72 13.0 1.8 609 71 12.7 2.0 42 58 12.0 2.1 0.02b
AST [U/l] 161 85 28.6 15.2 779 91 31.0 18.1 53 73 25.8 9.6 0.04b
ALT [U/l] 173 92 28.0 25.5 821 96 28.9 18.7 57 78 24.7 14.8 0.28b
creatinine [mg/dl] 189 100 0.8 0.3 856 100 0.8 0.3 73 100 1.1 0.6 <0.001b
CKD-EPI eGFR [ml/min/1.73m2] 189 100 100.8 21.4 856 100 101.1 21.4 73 100 81.5 30.4 <0.001b
eGFR category 1, 2 178 94 826 96 52 71 <0.001a
3a-5 11 6 30 4 21 29
Anaemiac yes 44 32 222 36 20 48 0.19a
no 93 68 387 64 22 52
missing 52 28 247 29 31 42
liver encymes yes 4 3 16 2 1 2 0.94a
>2•ULNd no 157 97 760 98 52 98
missing 28 15 80 9 20 27
liver encymes yes 1 1 0 0 0 0 0.08a
>5•ULNe no 159 99 775 100 53 100
missing 29 15 81 9 20 27
systolic blood <120 mmHg 40 27 284 40 22 37 0.004a
pressure 120–139 mmHg 56 38 250 35 16 27
> = 140 mmHg 53 36 177 25 22 38
missing 40 21 145 17 13 18

a χ2-test

b ANOVA, two-sided

c Anaemia was defined as Hgb below 13 [g/dl] for men, and below 12 [g/dl] for women.

d Liver disease was defined if at least ALT or AST were twice the upper limit of normal (ULN) of 50 [U/l] for men and 35 [U/l] for women.

e Presence of severe liver disease was assumed if at least ALT or AST were five times higher than the ULN.